Navigation Links
Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory,Drugs

with no serious adverse events. In blood samples taken from these volunteers and stimulated ex vivo, ARRY-797 was shown to inhibit the production of IL-1beta, TNF-alpha and PGE2. This effect was pronounced, with greater than 90 percent inhibition, and long-lasting with greater than 50 percent inhibition at 24 hours at the highest dose. ARRY-797 met its objective in this study and has advanced into MAD studies in both normal volunteers and cancer patients with hematological malignancies.

"We are pleased that both ARRY-162, our first-in-class MEK inhibitor for inflammation, and ARRY-797, our potent p38 inhibitor, have met their initial clinical endpoints," said Kevin Koch, Ph.D., President and Chief Scientific Officer. "We look forward to demonstrating the advantages of using these oral drugs to treat patient populations that would benefit from the suppression of inflammatory cytokines."

About Inflammatory Disease

Inflammation is a natural biologic response to injury or infectious attack to the human body. Unregulated inflammation results in a broad range of conditions, most of which are classified by the tissue or organ where the inflammation occurs. These conditions include rheumatoid arthritis (RA) in the joint, psoriasis in the skin, chronic obstructive pulmonary disease in the lung, fibrotic disease in the liver and kidney, Crohn's disease in the intestine, congestive hear failure and arteriosclerosis in the arteries, among others. Currently, some of the most effective treatments for these diseases are injectable protein therapeutics, which have significant cost and patient compliance issues. Injectable protein therapeutics currently on the market - such as Enbrel(R), Remicade(R), Humira(R) and Kineret(R) - bind to and/or modulate the activity of the inflammatory cytokines TNF-alpha or IL-1 and are utilized for the treatment of RA, psoriasis and Crohn's disease.

About ARRY-162 / Targeting MEK for Inflammation

MEK is an enzyme t
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
2. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
Post Your Comments:
(Date:4/24/2015)... CHAPEL HILL, N.C. , April 24, 2015 ... marketplace, organizations are establishing employee groups around the ... workforce and round-the-clock business hours. While there are ... becoming global, leaders must examine which best practices ... global operational excellence. According to ...
(Date:4/24/2015)... , Apr. 24, 2015 Research and Markets ... the "Global Biobanking Market 2015-2019" report to ... Biobanking market to grow at a CAGR of 7.07% ... market can be divided into two segments: Equipment and ... growth prospects of the Global Biobanking market for the ...
(Date:4/24/2015)... April 24, 2015 The National Institute ... the National Institutes of Health [NIH])  provided grants ... projects for the development of diagnostic tests for ... outbreaks at U.S. health facilities , the NIAID ... rapid, multiplexed and effective tests using alternative methods ...
Breaking Medicine Technology:Work Around the Clock: Building Effective Global Capabilities 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4
... Feb. 1, 2011 Anthera Pharmaceuticals, Inc. (Nasdaq: ... treat serious diseases associated with abnormal auto-immune responses and ... Thompson to its Board of Directors. Currently, Dr. Thompson ... founder and Managing Director of Strategicon Partners, an investment ...
...  China Medicine Corporation (OTC Bulletin Board: ... and distributor of Western pharmaceuticals, traditional Chinese medicines ... Republic of China, today announced that the Company ... Ministry of Agriculture ("MOA") for the Company,s proprietary ...
Cached Medicine Technology:Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors 2China Medicine Corporation Receives Manufacturing License for rADTZ 2China Medicine Corporation Receives Manufacturing License for rADTZ 3
(Date:4/24/2015)... 24, 2015 With years of experience ... is now proud to be partnered with a veterinary ... animals a year. This partnership has brought new payment ... , After providing an in-house payment plan for ... Hospital (VMTH) wanted to increase financing options available to ...
(Date:4/24/2015)... 2015 IntelliSoft Group, LLC, a ... contract management software, featured IntelliCred Version 14.2 during ... Annual Educational Conference (IAMSS) on April 23-24 ... Brook, Illinois. , Notable improvements available in IntelliSoft’s ... , Contract Linking: A new Contract Connection ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive ... & 2 suppliers, content providers, associations and government bodies. ... value chain, see them converge in Berlin. This year’s ... from those companies currently at the forefront of Europe’s ... on customer centric products, ParkTAG are one of the ...
(Date:4/24/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of ... forces are used worldwide, and how they would not be ... says that the nations have been trained to build up ... to the confusion and distrust. , “The nations believe ... forced compliance, unjust rules and laws, and the rape of ...
(Date:4/24/2015)... 2015 Recent research by the CareerBuilder ... therapists and their assistants are among the top 10 ... by the year 2023. , Physical therapists are ... growth and greatest potential for expansion in the future. ... that while physical therapists can offer great relief to ...
Breaking Medicine News(10 mins):Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:IntelliSoft Group Version 14.2 of IntelliCred featured at the Illinois Association of Medical Staff Services Annual Educational Conference 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3Health News:Armed Forces Would Not Be Necessary if Biblical Laws Were Followed, Says Yisrayl Hawkins in New Article 2Health News:Huntsville Medical Doctor Explains Why Physical Therapy May Not Treat Muscle Numbness Adequately 2
... Surayud Chulanont, has defended his government's move to allow the ... of US worries over intellectual property rights in the kingdom. ... we can explain our action to other countries as well ... This Tuesday, Health Minister Mongkol Na Songkhla will be traveling ...
... old man that visits a doc, there is a woman; much like ... for success. ,Some Older men need to be goaded ... has revealed The woman could be a wife, daughter or even a ... of men above 50 years visit a doctor only after being coaxed ...
... is not funny. Infact their love for the spirits has ... by the fallout of the binge drinking culture on the ... trend evident among all age groups, class, boundaries and cultural ... Australia in the next 20 years. Many Australians will be ...
... over a long period of time may decrease brain volume, ... Academy of Neurology's 59th Annual Meeting in Boston, April ... MRI scans of 1,839 people from the Framingham Offspring study, ... drinkers, low drinkers (one to seven drinks per week), moderate ...
... cells that can repair the most severe damage to the ... lie around and do nothing, but when neighboring cells ... A report on the discovery will appear online next week ... cells act like the Army Reserves of our nose, explains ...
... of Rhode Island have demonstrated a new way to target ... protein that acts like a nanosyringe to deliver tags or ... of the National Academy of Sciences. ... (Low) Insertion Peptide) can be injected into the abdomen of ...
Cached Medicine News:Health News:Thailand Unfazed As US Worries Over Copyright Violations 2Health News:Drinking Heavy Amounts of Alcohol Shrinks Your Brain 2Health News:When Smell Cells Fail They Call In Stem Cell Reserves 2Health News:Novel Technology to Locate and Treat Tumors 2
... Sepramesh Biosurgical Composite is designed for ... of a PPM mesh that has two ... mesh is coated with a layer of ... Biosurgery's Seprafilm® Adhesion Barrier). This coated side ...
... As Bard, The Hernia Repair Company, ... you may desire limited fibrous tissue in-growth ... as compared to polypropylene mesh. Like all ... prostheses, Reconix Patch produces a clinically proven, ...
... MYCROMESH® PLUS Biomaterial is the first ... for controlling potential operative contamination of ... contains two antimicrobial preservative agents, silver ... to inhibit bacterial colonization on the ...
... its introduction in 1958, Bard mesh has ... products are compared. Bard mesh was used ... developed the "tension-free" hernia repair many years ... safe and ideal" substance for permanent reinforcement ...
Medicine Products: